ANAnkush Kiran Niranjan

Ankush Kiran Niranjan

*This is an algorithmically generated author record based on publicly available information.

Ankush Kiran Niranjan has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Resurgence of Oropouche Virus: A Review on Evolution, Epidemiology, Pathophysiology, Vaccine Development and Global Health Preparedness

    by Aditya Agrawal, Praggaya Priya Lakra, Anil Gattani, Shailesh Kumar Patel, Rohini Gupta, Sriti Pandey, Ankush Kiran Niranjan, Ashok Kumar, Komal, Kumar Govil, et al.

    The Oropouche virus (OROV) is an emerging arbovirus grouped under Orthobunyavirus genus of Peribunyaviridae family, first identified in Trinidad and Tobago in 1955, and re-emerged as a serious public health concern in the Central and South Americas. Recently, numbers of OROV cases are on the rise with the 2024 outbreak documenting over 12,000 cases across endemic and newly affected regions, including first-time detections in Caribbean nations and imported cases in the United States, Canada, and Italy. The OROV has caused over 5,00,000 cases globally, with substantial underreporting owing to clinical similarities with Zika, chikungunya and dengue. The virus is mainly transmitted by midges viz. Culicoides paraensis (Goeldi), though alternative vectors such as Culex quinquefasciatus Say and Aedes serratus (Theobald) have also been identified. Clinical manifestations range from acute febrile illness with biphasic fever in approximately 60% of cases to severe complications including haemorrhagic symptoms along with neurological sequelae such as meningitis, encephalitis, and Guillain-Barre syndrome. The virus exhibits complex transmission cycles (urban and sylvatic) and reassortment-driven evolution. The evidence of vertical transmission has emerged, with documented cases of fetal microcephaly, stillbirths, and congenital malformations. Pathogenesis involves modulation of host innate immunity, particularly interferon responses. The virus demonstrates neuroinvasive potential through blood-brain barrier penetration and has been shown to persist in various tissues. Diagnostic challenges arise from non-specific clinical signs and limited access to specialized laboratory tests. At present, no specific treatment or vaccines against the OROV are available and management limited to supportive care. However, promising vaccine candidates such as live-attenuated, inactivated, and recombinant protein-based platforms are undergoing preclinical and clinical evaluation, offering hope for future preventive strategies against this neglected tropical disease.

  • Open Access

    Molecular Diagnosis and Phylogenetic Analysis of the Orf Virus from An Outbreak of Contagious Ecthyma at Rewa in Madhya Pradesh

    by S.D. Audarya, Y. Chatur, N. Shrivastava, A. Niranjan, A.K. Mishra

    Background: Contagious ecthyma is a viral pustular dermatitis in small ruminants. The disease is of zoonotic importance. Contagious ecthyma usually resolves spontaneously and has low mortality. The Orf virus causes contagious ecthyma, a member of the genus Parapoxvirus in the subfamily Chordopoxvirinae and family Poxviridae. Methods: The investigated goat farm experienced an outbreak of pustular dermatitis, especially in young goats. Scabs/tissue samples from lip commissures and over the lips of individual goats were collected in sterile eppendorf tubes, separately and stored in a frozen condition. Nucleic acid was extracted from these scabs with commercially available nucleic acid extraction kit. The extracted total deoxyribose nucleic acid was used in the Orf-specific B2L gene amplification in a molecular diagnosis method, polymerase chain reaction. The phylogenetic tree was constructed by using MEGA11 software tool. Result: Young goats showing clinical signs and overt scabby lesions on the lips were used to collect scabs/tissue samples in sterile containers. Total deoxyribose nucleic acid was used in the polymerase chain reaction to amplify 594 bp product specific to the B2L gene (envelope gene) of Orf virus confirming the outbreak of Contagious ecthyma. The amplified product was confirmed by the sequencing method. Phylogenetic analysis was made using bioinformatic tools. The Orf viral strain in the first such study in this area showed similarity to that of the strain from Hisar at a national level and to that of China at the international level.

  • Open Access

    Status of Infection during a Natural Outbreak of Brucellosis in Unvaccinated Buffaloes at a Livestock Farm of Madhya Pradesh in India by using Competitive Enzyme-linked Immunosorbent Assay

    by S.D. Audarya, Y. Chatur, A.K. Niranjan, D. Chhabra, R. Gangil, R. Sharda, R. Aich, A.K. Mishra

    Background: Brucellosis is one of India’s most important bacterial diseases of large ruminants. It is of economic importance. It is caused by members of the Brucella species and responsible for abortion in pregnant bovines usually during the first term and generally after the fifth month of gestation. Hence, livestock farm with a history of abortion in pregnant animals has to be investigated for Brucellosis. Methods: Whole blood samples (of 50 individual buffaloes) were collected aseptically from a herd of buffaloes experiencing a natural outbreak of Brucellosis. Extracted serum samples were tested after clarification in commercially procured competitive enzyme-linked immunosorbent assay for the serological laboratory diagnosis of Brucellosis. Result: Out of 50 buffalo serum samples tested by using commercially procured competitive enzyme-linked immunosorbent assay, a total of 24 buffalo serum samples tested positive for the presence of Antibodies against Brucella species. Overall seropositivity of 48% was recorded for Brucellosis in the investigated buffalo herd experiencing a natural infection in the present study even after long-term storage of serum samples at deep freezing conditions.

  • Isolation and Characterization of Staphylococcus aureus in Bovine Milk from Rewa, India

    by Shivani Rawat, Neeraj Shrivastava, Arpita Shrivastav, Shailendra Singh, P. K. Singh, Ankush Kiran Niranjan, Rajeev Ranjan

    Mastitis in dairy animals affect milk quality and quantity, animal health and welfare, antimicrobial use and economics of dairy farm, and antimicrobial residues in milk. Staphylococcus aureus is most common mastitis pathogen with ability to cause infections which are difficult to treat. The present study aimed to characterize the S. aureus strains associated with dairy animal with reference to its virulence, biofilm formation, antimicrobial resistance including methicillin and penicillin G resistance. A total of 100 bovine milk samples were screened by bacterial culture method, out of which 18 S. aureus and 6 methicillin-resistant S. aureus (MRSA) isolates were identified and characterized for virulence determinants. The strains were uniformly positive for the virulence determinants. However, the hemolysis in blood agar was found to be specific but not a sensitive criterion for virulence. The biofilm formation ability of the isolates showed 61.66% of S. aureus and 83.33% of MRSA strains were positive by Microtiter plate method. The biofilm formation genes (icaA and icaD) were detected in all the strains. The multi-drug resistance profile of the strains was studied by disk diffusion assay where over 70% of S. aureus strains were sensitive to all the anti-microbial agents (except penicillin) and only 33.33% of the strains had the MAR index above 0.2. All the MRSA strains (100%) had a MAR index of ≥ 0.2. All the strains showed resistance to penicillin which is considered as a prognostic marker for mastitis. The presence of penicillin and/or methicillin resistant, biofilm forming S. aureus mastitis strains can severely affect the treatment outcomes and economics of small dairy farmers of the region. Further studies to understand the population structure of the strains, by whole genome or traditional sequence-based methods and MIC values of antibiotics are required.


  • Open Access

    Mpox vaccination in global perspective: priorities and challenges

    by Jigyasa Rana, Shailesh Kumar Patel, Aditya Agrawal, Nikhil K. Channabasappa, Ankush K. Niranjan, Bhabesh Chandra Das, Megha K. Pandey, Sita Prasad Tiwari, Milan Mbbs Gaihre

    After the global panic created by COVID-19, the monkeypox (Mpox) virus emerged as a new challenge for the world population. As of 19 January 2023, a total of 84,733 cases across 110 countries/territories including 80 deaths has been reported. The virus has been transmitted to nonendemic countries in a short span of 6 months warranting WHO to declare Mpox, a Public Health Emergency of International Concern on 23 July 2022. As the Mpox virus is crossing geographical boundaries without established transmission patterns, there is an urgent need for new scientific strategies from global researchers to contain it before turning into the next pandemic. The control of Mpox outbreaks primarily relies on various public health measures such as proper surveillance, contact tracing, rapid diagnosis, isolation and care of patients, and vaccination. At present, there are three vaccines viz. ACAM2000, MVABN, and LC16 are in consideration and have been approved in several jurisdictions for ongoing Mpox outbreak. Prioritization of individuals along with the production of specific Mpox vaccine is need of the hour to meet out the global demand of Mpox vaccination.


  • Open Access

    Resurgence of cholera in the COVID-19 era: a global health concern

    by Ankush K. Niranjan, Shailesh K. Patel, Nikhil K. Channabasappa, Jigyasa Rana, Aditya Agrawal, Rakesh Kumar, Megha K. Pandey, Sita P. Tiwari, Devendra R. Msc Singh


  • Open Access

    Mpox and the need for improved diagnostics – correspondence

    by Shailesh Kumar Patel, Jigyasa Rana, Aditya Agrawal, Nikhil K. Channabasappa, Ankush Kiran Niranjan, Talha B. Emran

    An abstract is unavailable. This article is available as a PDF only.


  • Open Access

    Spillover of viruses and global concern: is simian haemorrhagic fever virus next in queue? – correspondence

    by Shailesh K. Patel, Ankush K. Niranjan, Nikhil K. Channabasappa, Jigyasa Rana, Aditya Agrawal, Talha B. Emran

    An abstract is unavailable. This article is available as a PDF only.


  • Open Access

    Vitamin D in therapy and management: armor against COVID-19 – correspondence

    by Nikhil K. Channabasappa, Shailesh Kumar Patel, Devendra Raj Msc Singh, Ankush Kiran Niranjan, Jigyasa Rana, Aditya Agrawal, Kumar Govil, Megha Katare Pandey, Sita Prasad Tiwari

    An abstract is unavailable. This article is available as a PDF only.

  • Open Access

    Omicron: a challenge to hybrid immunity – correspondence

    by Ankush K. Niranjan, Shailesh K. Patel, Talha B. Emran